iTeos Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITOS and other ETFs, options, and stocks.

About ITOS

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984.

CEO

Michel Detheux

CEOMichel Detheux

Employees

157

Employees157

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2012

Founded2012

Employees

157

Employees157

ITOS Key Statistics

Market cap

379.22M

Market cap379.22M

Price-Earnings ratio

-3.35

Price-Earnings ratio-3.35

Dividend yield

—

Dividend yield—

Average volume

241.93K

Average volume241.93K

High today

$10.61

High today$10.61

Low today

$10.01

Low today$10.01

Open price

$10.27

Open price$10.27

Volume

937.47K

Volume937.47K

52 Week high

$18.24

52 Week high$18.24

52 Week low

$8.20

52 Week low$8.20

iTeos Therapeutics

Why Robinhood?

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. Show more

ITOS Key Statistics

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984.